Related Experiment Video
Updated: Jun 28, 2026
03:49
Enhanced Cochlear Coverage and Hearing Preservation in High-Frequency Hearing Loss via Electric Acoustic Stimulation with Longer Electrode
Published on: October 11, 2024
[Cochlear ischemia: from fundamental data to clinical hope]
1Laboratoire de biophysique sensorielle (EA 2667), service d'ORL et de chirurgie cervicofaciale, hôpital Gabriel-Montpied, CHU de Clermont-Ferrand, 58, rue Montalembert, 63000 Clermont-Ferrand, France. tmom@chu-clermontferrand.fr
Summary
Cochlear ischemia monitoring uses animal models and tools like otoacoustic emissions. Early, noninvasive detection in humans remains a clinical challenge for conditions like sudden hearing loss.
Area of Science:
- Otoacoustic emissions
- Cochlear potentials
- Mammalian in vivo models
Background:
- Cochlear ischemia poses risks to hearing function.
- Understanding functional consequences is crucial for auditory health.
- Current detection methods have limitations.
Purpose of the Study:
- To review functional consequences of cochlear ischemia.
- To identify tools for detecting cochlear ischemia.
- To assess current detection capabilities.
Main Methods:
- Review of integrated in vivo mammalian models.
- Analysis of monitoring tools: cochlear potentials and otoacoustic emissions.
- Laser Doppler velocimetry for ischemia measurement.
Main Results:
- Cochlear ischemia can be monitored via cochlear potentials and otoacoustic emissions.
- The cochlea shows resistance to short, reversible ischemia.
- Indirect monitoring is possible during cerebellopontine angle surgery.
- Noninvasive, direct detection in clinical practice is currently unavailable.
Conclusions:
- Integrated models advance understanding of cochlear ischemia.
- Clinical need for early, noninvasive detection of cochlear ischemia.
- Application in sudden hearing loss cases is a future goal.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...